Loading…
AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma
BACKGROUND: This year, the 7th edition of the AJCC staging manual has for the first time attributed a unique pTNM staging to intrahepatic cholangiocarcinoma (IHCC) that is intended to replace the 2 Western and ideally also the 2 Eastern systems currently in use. This proposal, which has not yet been...
Saved in:
Published in: | Cancer 2011-05, Vol.117 (10), p.2170-2177 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c2382-490dc37dccbdb154912f478a96103b37d55b7d646bc53f6cf4324fe0882558103 |
---|---|
cites | |
container_end_page | 2177 |
container_issue | 10 |
container_start_page | 2170 |
container_title | Cancer |
container_volume | 117 |
creator | Farges, Olivier Fuks, David Le Treut, Yves‐Patrice Azoulay, Daniel Laurent, Alexis Bachellier, Philippe Nuzzo, Gennaro Belghiti, Jacques Pruvot, François René Regimbeau, Jean Marc |
description | BACKGROUND:
This year, the 7th edition of the AJCC staging manual has for the first time attributed a unique pTNM staging to intrahepatic cholangiocarcinoma (IHCC) that is intended to replace the 2 Western and ideally also the 2 Eastern systems currently in use. This proposal, which has not yet been validated, was tested in the current study.
METHODS:
Among 522 patients operated on with curative intent for an IHCC between 1994 and 2008 in tertiary hepatobiliary centers, those with mass‐forming‐type IHCCs, an R0 resection, and accurate pathological node staging were retained for evaluation. The distribution of these patients and their actuarial survival in the new TNM stages (as well as in the 4 previous ones) were compared.
RESULTS:
Only 163 patients fulfilled the inclusion criteria, mainly because of the lack of routine lymphadenectomy, but patients and tumors characteristics of this population were representative. These patients were evenly distributed between AJCC 7th edition stages (stage I, 28%; stage II, 32%; stage III, 35%), which was not the case for the other systems. With an average follow‐up of 34 months in survivors, the AJCC 7th edition was more discriminating than the others in predicting survival (median for stage I not reached; for stage II, 53 months, P = .01; for stage III, 16 months, P < .0001). Survival of these patients according to the 2 Japanese classifications was identical to that anticipated.
CONCLUSIONS:
The 7th edition is clinically relevant and may be applicable worldwide, provided routine lymphadenectomy at the time of surgery for IHCC becomes the standard of care. Cancer 2011. © 2010 American Cancer Society.
This year the AJCC has implemented a new staging system for intrahepatic cholangiocarcinoma that has not been validated yet. The present study shows that it is more discriminative than the 2 Western and the 2 Eastern classifications previously used. |
doi_str_mv | 10.1002/cncr.25712 |
format | article |
fullrecord | <record><control><sourceid>wiley</sourceid><recordid>TN_cdi_wiley_primary_10_1002_cncr_25712_CNCR25712</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CNCR25712</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2382-490dc37dccbdb154912f478a96103b37d55b7d646bc53f6cf4324fe0882558103</originalsourceid><addsrcrecordid>eNotkF1LwzAYhYMoOKc3_oL8gc58Nu3lKH5M5gSZ4F1J3yZbpEtHkjF24X-3nV6953AOB94HoXtKZpQQ9gAewoxJRdkFmlBSqoxQwS7RhBBSZFLwr2t0E-P3YBWTfIJ-5q9VhVXaYtO65HqPe4vXqzcck944v8Ea4BB0Mt0Jty5CcDvnBxtxf0jQ70Zh8V4nZ3yK-OiGpWCigaSbzmDnU9BbM-aAYdt32m9cDzqA8_1O36Irq7to7v7vFH0-Pa6rl2z5_ryo5ssMGC9YJkrSAlctQNM2VIqSMitUocucEt4MgZSNanORNyC5zcEKzoQ1pCiYlMXQmSL6t3t0nTnV--ELHU41JfVIrR6p1WdqdbWqPs6K_wJZcGS3</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma</title><source>Wiley-Blackwell Read & Publish Collection</source><source>EZB Electronic Journals Library</source><creator>Farges, Olivier ; Fuks, David ; Le Treut, Yves‐Patrice ; Azoulay, Daniel ; Laurent, Alexis ; Bachellier, Philippe ; Nuzzo, Gennaro ; Belghiti, Jacques ; Pruvot, François René ; Regimbeau, Jean Marc</creator><creatorcontrib>Farges, Olivier ; Fuks, David ; Le Treut, Yves‐Patrice ; Azoulay, Daniel ; Laurent, Alexis ; Bachellier, Philippe ; Nuzzo, Gennaro ; Belghiti, Jacques ; Pruvot, François René ; Regimbeau, Jean Marc</creatorcontrib><description>BACKGROUND:
This year, the 7th edition of the AJCC staging manual has for the first time attributed a unique pTNM staging to intrahepatic cholangiocarcinoma (IHCC) that is intended to replace the 2 Western and ideally also the 2 Eastern systems currently in use. This proposal, which has not yet been validated, was tested in the current study.
METHODS:
Among 522 patients operated on with curative intent for an IHCC between 1994 and 2008 in tertiary hepatobiliary centers, those with mass‐forming‐type IHCCs, an R0 resection, and accurate pathological node staging were retained for evaluation. The distribution of these patients and their actuarial survival in the new TNM stages (as well as in the 4 previous ones) were compared.
RESULTS:
Only 163 patients fulfilled the inclusion criteria, mainly because of the lack of routine lymphadenectomy, but patients and tumors characteristics of this population were representative. These patients were evenly distributed between AJCC 7th edition stages (stage I, 28%; stage II, 32%; stage III, 35%), which was not the case for the other systems. With an average follow‐up of 34 months in survivors, the AJCC 7th edition was more discriminating than the others in predicting survival (median for stage I not reached; for stage II, 53 months, P = .01; for stage III, 16 months, P < .0001). Survival of these patients according to the 2 Japanese classifications was identical to that anticipated.
CONCLUSIONS:
The 7th edition is clinically relevant and may be applicable worldwide, provided routine lymphadenectomy at the time of surgery for IHCC becomes the standard of care. Cancer 2011. © 2010 American Cancer Society.
This year the AJCC has implemented a new staging system for intrahepatic cholangiocarcinoma that has not been validated yet. The present study shows that it is more discriminative than the 2 Western and the 2 Eastern classifications previously used.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.25712</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>biliary tumor ; cholangiocarcinoma ; primary liver tumor ; staging ; surgery</subject><ispartof>Cancer, 2011-05, Vol.117 (10), p.2170-2177</ispartof><rights>Copyright © 2010 American Cancer Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2382-490dc37dccbdb154912f478a96103b37d55b7d646bc53f6cf4324fe0882558103</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Farges, Olivier</creatorcontrib><creatorcontrib>Fuks, David</creatorcontrib><creatorcontrib>Le Treut, Yves‐Patrice</creatorcontrib><creatorcontrib>Azoulay, Daniel</creatorcontrib><creatorcontrib>Laurent, Alexis</creatorcontrib><creatorcontrib>Bachellier, Philippe</creatorcontrib><creatorcontrib>Nuzzo, Gennaro</creatorcontrib><creatorcontrib>Belghiti, Jacques</creatorcontrib><creatorcontrib>Pruvot, François René</creatorcontrib><creatorcontrib>Regimbeau, Jean Marc</creatorcontrib><title>AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma</title><title>Cancer</title><description>BACKGROUND:
This year, the 7th edition of the AJCC staging manual has for the first time attributed a unique pTNM staging to intrahepatic cholangiocarcinoma (IHCC) that is intended to replace the 2 Western and ideally also the 2 Eastern systems currently in use. This proposal, which has not yet been validated, was tested in the current study.
METHODS:
Among 522 patients operated on with curative intent for an IHCC between 1994 and 2008 in tertiary hepatobiliary centers, those with mass‐forming‐type IHCCs, an R0 resection, and accurate pathological node staging were retained for evaluation. The distribution of these patients and their actuarial survival in the new TNM stages (as well as in the 4 previous ones) were compared.
RESULTS:
Only 163 patients fulfilled the inclusion criteria, mainly because of the lack of routine lymphadenectomy, but patients and tumors characteristics of this population were representative. These patients were evenly distributed between AJCC 7th edition stages (stage I, 28%; stage II, 32%; stage III, 35%), which was not the case for the other systems. With an average follow‐up of 34 months in survivors, the AJCC 7th edition was more discriminating than the others in predicting survival (median for stage I not reached; for stage II, 53 months, P = .01; for stage III, 16 months, P < .0001). Survival of these patients according to the 2 Japanese classifications was identical to that anticipated.
CONCLUSIONS:
The 7th edition is clinically relevant and may be applicable worldwide, provided routine lymphadenectomy at the time of surgery for IHCC becomes the standard of care. Cancer 2011. © 2010 American Cancer Society.
This year the AJCC has implemented a new staging system for intrahepatic cholangiocarcinoma that has not been validated yet. The present study shows that it is more discriminative than the 2 Western and the 2 Eastern classifications previously used.</description><subject>biliary tumor</subject><subject>cholangiocarcinoma</subject><subject>primary liver tumor</subject><subject>staging</subject><subject>surgery</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNotkF1LwzAYhYMoOKc3_oL8gc58Nu3lKH5M5gSZ4F1J3yZbpEtHkjF24X-3nV6953AOB94HoXtKZpQQ9gAewoxJRdkFmlBSqoxQwS7RhBBSZFLwr2t0E-P3YBWTfIJ-5q9VhVXaYtO65HqPe4vXqzcck944v8Ea4BB0Mt0Jty5CcDvnBxtxf0jQ70Zh8V4nZ3yK-OiGpWCigaSbzmDnU9BbM-aAYdt32m9cDzqA8_1O36Irq7to7v7vFH0-Pa6rl2z5_ryo5ssMGC9YJkrSAlctQNM2VIqSMitUocucEt4MgZSNanORNyC5zcEKzoQ1pCiYlMXQmSL6t3t0nTnV--ELHU41JfVIrR6p1WdqdbWqPs6K_wJZcGS3</recordid><startdate>20110515</startdate><enddate>20110515</enddate><creator>Farges, Olivier</creator><creator>Fuks, David</creator><creator>Le Treut, Yves‐Patrice</creator><creator>Azoulay, Daniel</creator><creator>Laurent, Alexis</creator><creator>Bachellier, Philippe</creator><creator>Nuzzo, Gennaro</creator><creator>Belghiti, Jacques</creator><creator>Pruvot, François René</creator><creator>Regimbeau, Jean Marc</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope/></search><sort><creationdate>20110515</creationdate><title>AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma</title><author>Farges, Olivier ; Fuks, David ; Le Treut, Yves‐Patrice ; Azoulay, Daniel ; Laurent, Alexis ; Bachellier, Philippe ; Nuzzo, Gennaro ; Belghiti, Jacques ; Pruvot, François René ; Regimbeau, Jean Marc</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2382-490dc37dccbdb154912f478a96103b37d55b7d646bc53f6cf4324fe0882558103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>biliary tumor</topic><topic>cholangiocarcinoma</topic><topic>primary liver tumor</topic><topic>staging</topic><topic>surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Farges, Olivier</creatorcontrib><creatorcontrib>Fuks, David</creatorcontrib><creatorcontrib>Le Treut, Yves‐Patrice</creatorcontrib><creatorcontrib>Azoulay, Daniel</creatorcontrib><creatorcontrib>Laurent, Alexis</creatorcontrib><creatorcontrib>Bachellier, Philippe</creatorcontrib><creatorcontrib>Nuzzo, Gennaro</creatorcontrib><creatorcontrib>Belghiti, Jacques</creatorcontrib><creatorcontrib>Pruvot, François René</creatorcontrib><creatorcontrib>Regimbeau, Jean Marc</creatorcontrib><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Farges, Olivier</au><au>Fuks, David</au><au>Le Treut, Yves‐Patrice</au><au>Azoulay, Daniel</au><au>Laurent, Alexis</au><au>Bachellier, Philippe</au><au>Nuzzo, Gennaro</au><au>Belghiti, Jacques</au><au>Pruvot, François René</au><au>Regimbeau, Jean Marc</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma</atitle><jtitle>Cancer</jtitle><date>2011-05-15</date><risdate>2011</risdate><volume>117</volume><issue>10</issue><spage>2170</spage><epage>2177</epage><pages>2170-2177</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>BACKGROUND:
This year, the 7th edition of the AJCC staging manual has for the first time attributed a unique pTNM staging to intrahepatic cholangiocarcinoma (IHCC) that is intended to replace the 2 Western and ideally also the 2 Eastern systems currently in use. This proposal, which has not yet been validated, was tested in the current study.
METHODS:
Among 522 patients operated on with curative intent for an IHCC between 1994 and 2008 in tertiary hepatobiliary centers, those with mass‐forming‐type IHCCs, an R0 resection, and accurate pathological node staging were retained for evaluation. The distribution of these patients and their actuarial survival in the new TNM stages (as well as in the 4 previous ones) were compared.
RESULTS:
Only 163 patients fulfilled the inclusion criteria, mainly because of the lack of routine lymphadenectomy, but patients and tumors characteristics of this population were representative. These patients were evenly distributed between AJCC 7th edition stages (stage I, 28%; stage II, 32%; stage III, 35%), which was not the case for the other systems. With an average follow‐up of 34 months in survivors, the AJCC 7th edition was more discriminating than the others in predicting survival (median for stage I not reached; for stage II, 53 months, P = .01; for stage III, 16 months, P < .0001). Survival of these patients according to the 2 Japanese classifications was identical to that anticipated.
CONCLUSIONS:
The 7th edition is clinically relevant and may be applicable worldwide, provided routine lymphadenectomy at the time of surgery for IHCC becomes the standard of care. Cancer 2011. © 2010 American Cancer Society.
This year the AJCC has implemented a new staging system for intrahepatic cholangiocarcinoma that has not been validated yet. The present study shows that it is more discriminative than the 2 Western and the 2 Eastern classifications previously used.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><doi>10.1002/cncr.25712</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-543X |
ispartof | Cancer, 2011-05, Vol.117 (10), p.2170-2177 |
issn | 0008-543X 1097-0142 |
language | eng |
recordid | cdi_wiley_primary_10_1002_cncr_25712_CNCR25712 |
source | Wiley-Blackwell Read & Publish Collection; EZB Electronic Journals Library |
subjects | biliary tumor cholangiocarcinoma primary liver tumor staging surgery |
title | AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T17%3A33%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AJCC%207th%20edition%20of%20TNM%20staging%20accurately%20discriminates%20outcomes%20of%20patients%20with%20resectable%20intrahepatic%20cholangiocarcinoma&rft.jtitle=Cancer&rft.au=Farges,%20Olivier&rft.date=2011-05-15&rft.volume=117&rft.issue=10&rft.spage=2170&rft.epage=2177&rft.pages=2170-2177&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/cncr.25712&rft_dat=%3Cwiley%3ECNCR25712%3C/wiley%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2382-490dc37dccbdb154912f478a96103b37d55b7d646bc53f6cf4324fe0882558103%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |